Option Care Health Inc. (OPCH)
NASDAQ: OPCH · Services-Home Health Care Services · Bannockburn, IL
Our rating: Positive
Positive reaffirmed at $31.65, moderate conviction, November 6, 2026.
Breaks if: The Positive view turns Cautious if reported revenue growth decelerates to below 6% year-over-year in either of the next two quarterly filings — that would strip the growth premium from a 25× earnings multiple on a 3.7% margin business, leaving the valuation without a logical anchor. Separately, if net margin falls below 2.5% for two consecutive quarters, it would indicate that reimbursement or labor cost pressures are compressing the business faster than volume gains can compensate, and the investment case would shift from 'growing franchise at a full price' to 'margin story at risk'.
Key figures
| Market value | $4.7B |
|---|---|
| Revenue, last 12 months | $5.8B |
| Net income, last 12 months | $215M |
| Free cash flow, last 12 months | $282M |
| Price to earnings | 22.0× |
| Free cash flow yield | 6.0% |
| Dividend yield | 0.0% |
| Operating margin | 5.9% |
| Return on equity | 16.0% |
| Beta to the S&P 500 | 0.30 |
| Volatility, annualized | 43.6% |
Reported quarters
| Quarter ending | Revenue | Year on year | Earnings per share | Free cash flow |
|---|---|---|---|---|
| September 30, 2026 | $1.5B | 4.1% | $0.38 | $108M |
| June 30, 2026 | $1.4B | 1.9% | $0.35 | $173M |
| March 31, 2026 | $1.4B | 1.3% | $0.29 | −$21M |
| December 31, 2025 | $1.5B | 8.8% | $0.36 | $22M |
| September 30, 2025 | $1.4B | 12.2% | $0.32 | $130M |
| June 30, 2025 | $1.4B | 15.4% | $0.31 | $81M |
| March 31, 2025 | $1.3B | 16.3% | $0.28 | −$17M |
| December 31, 2024 | $1.3B | 19.7% | $0.36 | $26M |
Three-model forecasts for the next quarter
Written November 21, 2026, before the report. Each settles from the SEC filing.
- Revenue for the quarter is at least $1.52B: Claude 52%, Gemini 85%, Mistral 60%
- Diluted earnings per share are at least $0.36: Claude 48%, Gemini 95%, Mistral 82%
- Free cash flow for the quarter is at least $0.02B: Claude 62%, Gemini 75%, Mistral 72%
14 ledger entries and 91 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.